Vedolizumab versus ustekinumab in Crohn’s disease with prior anti-tumor necrosis factor failure: an updated meta-analysis
Article in European Journal of Gastroenterology & Hepatology (July 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Ustekinumab or Vedolizumab after Failure of Anti-TNF Agents in Crohn’s Disease: A Review of Comparative Effectiveness Studies
Article in Journal of Clinical Medicine (April 2024)
Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis
Article in Therapeutic Advances in Gastroenterology (January 2024)